Aaron Royston

Aaron Royston has made 37 investments in companies such as: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune, Metacrine, Seragon Pharmaceuticals, NorthSea Therapeutics, Solstice Biologics, Outlook Therapeutics, Stargazer Pharmaceuticals, Heart Metabolics, Turning Point Therapeutics, Precision BioSciences, Aeovian Pharmaceuticals, Akero Therapeutics, Harmony Biosciences, RayzeBio, Ventyx Biosciences, Elevation Oncology, ALX Oncology, Impel NeuroPharma, Checkmate Pharmaceuticals, Apellis Pharmaceuticals, Tallac Therapeutics, Bellicum Pharmaceuticals, Cytos, Artiva Biotherapeutics, Stem Cell Therapeutics, VYNE Therapeutics, Cidara Therapeutics, Arrakis Therapeutics, INBRACE, Pharvaris, Neurogastrx, NFlection Therapeutics, Aragon Pharmaceuticals, Fog Pharmaceuticals.

Location of Aaron Royston is San Francisco, United States.

The free version of Angel Match provides limited data for Aaron Royston. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.


Aaron Royston is a Managing Partner and he his investment types are: Private Equity Firm.
Aaron Royston focuses investing in industries such as: Biopharma, Biotechnology, Life Science, Therapeutics, Health Care, Pharmaceutical, Women Founded, Medical Device, Manufacturing, Medical.

A short brief about investor:

About

Past investments

  • Attralus
  • Aurinia Pharmaceuticals
  • Labrys Biologics
  • Adaptimmune
  • Metacrine
  • Seragon Pharmaceuticals
  • NorthSea Therapeutics
  • Solstice Biologics
  • Outlook Therapeutics
  • Stargazer Pharmaceuticals
  • Heart Metabolics
  • Turning Point Therapeutics
  • Precision BioSciences
  • Aeovian Pharmaceuticals
  • Akero Therapeutics
  • Harmony Biosciences
  • RayzeBio
  • Ventyx Biosciences
  • Elevation Oncology
  • ALX Oncology
  • Impel NeuroPharma
  • Checkmate Pharmaceuticals
  • Apellis Pharmaceuticals
  • Tallac Therapeutics
  • Bellicum Pharmaceuticals
  • Cytos
  • Artiva Biotherapeutics
  • Stem Cell Therapeutics
  • VYNE Therapeutics
  • Cidara Therapeutics
  • Arrakis Therapeutics
  • INBRACE
  • Pharvaris
  • Neurogastrx
  • NFlection Therapeutics
  • Aragon Pharmaceuticals
  • Fog Pharmaceuticals

Social media:

Available after registration.